Components:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
A potent androgenic steroid and major product secreted by the leydig cells of the testis. Its production is stimulated by luteinizing hormone from the pituitary gland. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to dihydrotestosterone or estradiol.
Cadesol is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Surgically induced anephric patients have been reported to be less responsive.
Managing anemia caused by kidney problems. It may also be used to treat other conditions as determined by your doctor.
Cadesol is an anabolic steroid. It works by increasing the growth of certain tissues in the body and has been shown to improve the oxygen-carrying ability of blood by increasing hemoglobin and the size of red blood cells.
Applies to the following strengths: phenpropionate 25 mg/mL; phenpropionate 50 mg/mL; decanoate 50 mg/mL; decanoate 100 mg/mL; decanoate 200 mg/mL
Usual Adult Dose for:
- Breast Cancer
- Anemia Associated with Chronic Renal Failure
Usual Pediatric Dose for:
- Anemia Associated with Chronic Renal Failure
Usual Adult Dose for Breast Cancer
Control of metastatic breast cancer in women:
50 to 100 mg by deep intramuscular injection once a week.
Usual Adult Dose for Anemia Associated with Chronic Renal Failure
female: 50 to 100 mg by deep intramuscular injection once a week.
male: 100 to 200 mg by deep intramuscular injection once a week.
Usual Pediatric Dose for Anemia Associated with Chronic Renal Failure
2 to 13 years:
25 to 50 mg by deep intramuscular injecyion every 3 to 4 weeks.
> 13 years:
female: 50 to 100 mg by deep intramuscular injection once a week.
male: 100 to 200 mg by deep intramuscular injection once a week.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
More about Cadesol
- Cadesol Side Effects
- During Pregnancy
- Drug Interactions
- Drug class: androgens and anabolic steroids
Professional resources
- Cadesol (FDA)
Related treatment guides
- Anemia Associated with Chronic Renal Failure
- Breast Cancer
See also:
What is the most important information I should know about Cadesol?
Androgens are contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate.
AndroGel® is not indicated for use in women, has not been evaluated in women, and must not be used in women.
Pregnant women should avoid skin contact with AndroGel® application sites in men. Cadesol may cause fetal harm. In the event that unwashed or unclothed skin to which AndroGel® has been applied does come in direct contact with the skin of a pregnant woman, the general area of contact on the woman should be washed with soap and water as soon as possible. In vitro studies show that residual testosterone is removed from the skin surface by washing with soap and water.
AndroGel® should not be used in patients with known hypersensitivity to any of its ingredients, including testosterone USP that is chemically synthesized from soy.
Use Cadesol as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Cadesol is usually administered as an injection at your doctor's office, hospital, or clinic. If you are using Cadesol at home, carefully follow the injection procedures taught to you by your health care provider.
- If Cadesol contains particles or is discolored, or if the vial is cracked or damaged in any way, do not use it.
- Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Dispose of properly after use. Ask your doctor or pharmacist to explain local regulations for proper disposal.
- If you miss a dose of Cadesol, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Cadesol.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.How to use Ade topical
Decrease Cadesol levels w/ enzyme-inducing agents. Increase Cadesol levels w/ enzyme-inhibiting drugs. May improve glucose tolerance & decrease the need for insulin or other antidiabetic medicines in diabetics. High doses may enhance the anticoagulant action of coumarin type agents. May enhance oedema formations when co-administered w/ ACTH or corticosteroids. May decrease levels of thyroxine-binding globulin resulting in decreased total T4 serum levels & increase resin uptake of T3 & T4. Combination w/ recombinant human erythropoietin especially in females may enable a reduction of the erythropoietin dose to reduce anaemia.
See also:
What are the possible side effects of Cadesol?
Hepatic:
Hepatocellular neoplasms and peliosis hepatis have been reported in association with long-term androgenic anabolic steroid therapy.
Genitourinary System:
In men.
- Prepubertal: Phallic enlargement and increased frequency of erections.
- Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis and bladder irritability.
In women: Clitoral enlargement, menstrual irregularities. In both sexes: Increased or decreased libido.
CNS:
Habituation, excitation, insomnia, depression.
Gastrointestinal:
Nausea, vomiting, diarrhea.
Hematologic:
Bleeding in patients on concomitant anticoagulant therapy.
Breast:
Gynecomastia.
Larynx:
Deepening of the voice in women.
Hair:
Hirsutism and male pattern of baldness in women.
Skin:
Acne (especially in women and prepubertal boys.)
Skeletal:
Premature closure of epiphyses in children.
Fluid and Electrolytes:
Edema, retention of serum electrolytes (sodium, chloride, potassium, phosphate, calcium).
Metabolic/Endocrine:
Decreased glucose tolerance, increased serum levels of low-density lipoprotein and decreased levels of high-density lipoprotein, increased creatine and creatinine excretion, increased serum levels of creatinine phosphokinase (CPK). Some virilizing changes in women are irreversible even after prompt discontinuance of therapy and are not prevented by concomitant use of estrogens.